Cargando…
From Biomarker to Mechanism? F2-isoprostanes in Pulmonary Fibrosis
Autores principales: | Thatcher, Thomas H., Peters-Golden, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716893/ https://www.ncbi.nlm.nih.gov/pubmed/35763804 http://dx.doi.org/10.1164/rccm.202205-0914ED |
Ejemplares similares
-
F(2)-Isoprostanes as Novel Biomarkers for Type 2 Diabetes: a Review
por: Kaviarasan, Subramanian, et al.
Publicado: (2009) -
Urinary F(2)-Isoprostanes as a Biomarker of Reduced Risk of Type 2 Diabetes
por: Il'yasova, Dora, et al.
Publicado: (2012) -
Predictive Role of F(2)-Isoprostanes as Biomarkers for Brain Damage after Neonatal Surgery
por: Stolwijk, L. J., et al.
Publicado: (2017) -
Urinary F2-Isoprostanes and Metabolic Markers of Fat Oxidation
por: Il'yasova, Dora, et al.
Publicado: (2015) -
Isoprostanes in Veterinary Medicine: Beyond a Biomarker
por: Putman, Ashley K., et al.
Publicado: (2021)